Fuan Pharmaceutical Group Co (300194) — Financial Flexibility Index
Fuan Pharmaceutical Group Co (300194) has a Financial Flexibility Index of 0.08x as of September 2025. Free cash flow of CN¥123.08 Million (operating CF CN¥100.27 Million minus capex CN¥22.81 Million) represents 0% of total liabilities (CN¥1.51 Billion). Also explore Fuan Pharmaceutical Group Co equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Fuan Pharmaceutical Group Co Financial Flexibility Index (2007–2024)
Historical Financial Flexibility Index trend for Fuan Pharmaceutical Group Co across 18 annual periods. Check Fuan Pharmaceutical Group Co strategic capital allocation to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Fuan Pharmaceutical Group Co (2007–2024)
Year-by-year free cash flow to debt coverage for Fuan Pharmaceutical Group Co. For the full company profile including market capitalisation, see 300194 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.35x | CN¥545.38 Million | CN¥303.59 Million | CN¥1.58 Billion | ▲ +15.8% |
| 2023 | 0.30x | CN¥544.66 Million | CN¥328.98 Million | CN¥1.83 Billion | ▼ -20.3% |
| 2022 | 0.37x | CN¥722.60 Million | CN¥339.50 Million | CN¥1.93 Billion | ▲ +2.7% |
| 2021 | 0.36x | CN¥670.16 Million | CN¥257.13 Million | CN¥1.84 Billion | ▲ +1.8% |
| 2020 | 0.36x | CN¥507.09 Million | CN¥162.55 Million | CN¥1.42 Billion | ▼ -48.6% |
| 2019 | 0.70x | CN¥519.42 Million | CN¥295.63 Million | CN¥746.59 Million | ▲ +4.2% |
| 2018 | 0.67x | CN¥399.84 Million | CN¥267.68 Million | CN¥598.62 Million | ▼ -35.7% |
| 2017 | 1.04x | CN¥537.99 Million | CN¥453.37 Million | CN¥518.24 Million | ▼ -14.7% |
| 2016 | 1.22x | CN¥528.08 Million | CN¥374.16 Million | CN¥434.00 Million | ▲ +64.8% |
| 2015 | 0.74x | CN¥253.19 Million | CN¥161.03 Million | CN¥342.91 Million | ▲ +283.1% |
| 2014 | 0.19x | CN¥24.03 Million | CN¥-31.27 Million | CN¥124.69 Million | ▼ -89.8% |
| 2013 | 1.89x | CN¥261.58 Million | CN¥89.61 Million | CN¥138.47 Million | ▼ -18.5% |
| 2012 | 2.32x | CN¥195.21 Million | CN¥62.77 Million | CN¥84.20 Million | ▲ +74.4% |
| 2011 | 1.33x | CN¥165.78 Million | CN¥64.85 Million | CN¥124.69 Million | ▼ -50.4% |
| 2010 | 2.68x | CN¥174.48 Million | CN¥105.74 Million | CN¥65.09 Million | ▲ +215.3% |
| 2009 | 0.85x | CN¥93.79 Million | CN¥62.75 Million | CN¥110.31 Million | ▼ -6.7% |
| 2008 | 0.91x | CN¥83.71 Million | CN¥49.23 Million | CN¥91.83 Million | ▲ +97.5% |
| 2007 | 0.46x | CN¥33.50 Million | CN¥18.92 Million | CN¥72.58 Million | — |